STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
111
13F, latest reported quarter
Conversions, 180 days
4
Codes C/M, not in net · $742.6K priced
What the filings say about UVSP
Insiders, 180 days
-$1.6M net sold
6 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-05-12
Planned sales (Form 144), 90 days
$340.0K
1 notice
Univest Financial insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, UNIVEST FINANCIAL Corp insiders sold a net $1.6M of stock across 74 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Aug 27, 2025.
The trade is 10.6% of the 47,238 shares held after it.
1 other insider sold within 30 days.
111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director PETRO THOMAS M sold about $208.4K of UVSP on Aug 24, 2026; 1 other insider sold within 30 days and 111 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 32.4% of the 24,684 shares held after it.
1 other insider sold within 30 days.
111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Turner Michael L. sold about $344.3K of UVSP on Aug 13, 2026; 1 other insider sold within 30 days and 111 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Dec 12, 2025.
The trade is 7.7% of the 35,975 shares held after it.
2 other insiders sold within 30 days.
111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Sr EVP & Chief Risk Officer Santana Megan D sold about $113.8K of UVSP on Jun 8, 2026; 2 other insiders sold within 30 days and 111 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Dec 12, 2025.
The trade is 8.6% of the 24,228 shares held after it.
2 other insiders sold within 30 days.
111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Sr EVP & CFO Richardson Brian J sold about $85.5K of UVSP on Jun 8, 2026; 2 other insiders sold within 30 days and 111 funds added in the latest 13F quarter.
13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Dec 12, 2025.
The trade is 12.6% of the 110,513 shares held after it.
2 other insiders sold within 30 days.
111 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman, President & CEO SCHWEITZER JEFFREY M sold about $570.0K of UVSP on Jun 8, 2026, the largest insider sale at the company since 2023; 2 other insiders sold within 30 days and 111 funds added in the latest 13F quarter.
74 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
UVSP planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Michael Turner
Filed 2026-08-13
$340.0K
UVSP mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Select Banking Portfolio
$9.5M position · as of 2026-05-31
2.1%
Pzena Small Cap Value Fund
$1.4M position · as of 2026-05-31
1.5%
Small Cap Core Trust
$4.3M position · as of 2026-06-30
1.2%
Small Cap Core Fund
$20.8M position · as of 2026-07-31
1.1%
Touchstone Funds Group Trust-Touchstone Small Cap Value Fund
$2.1M position · as of 2026-06-30
0.9%
Royce Capital Fund - Small-Cap Portfolio
$1.4M position · as of 2026-06-30
0.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · 1.
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.1M
$2.3M
$932.7K
+88%
+29%
2024
$1.9M
$2.5M
$851.3K
+64%
+24%
2023
$1.6M
$1.4M
$717.3K
+18%
+6%
2022
$1.8M
$1.7M
$806.2K
+35%
+14%
2021
$1.6M
$2.1M
$691.3K
+50%
+40%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.6M sold by insiders over 180 days, 111 funds added last quarter, $340.0K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$339.6M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM UVSP
FY Dec 2025
$328.1M
FY Dec 2024
$299.2M
FY Dec 2023
$0
FY Dec 2022
$0
FY Dec 2021
$0
Jun 2026
$84.4M
Mar 2026
$87.5M
Dec 2025
$84.6M
Sep 2025
$83.2M
Jun 2025
$81.0M
Mar 2025
$79.2M
Dec 2024
$76.8M
Sep 2024
$73.4M
At each fiscal year end
Single quarter
Net margin, TTM
+29.0%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM UVSP
FY Dec 2025
+27.7%
FY Dec 2024
+25.4%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+27.2%
Mar 2026
+31.0%
Dec 2025
+26.9%
Sep 2025
+30.8%
Jun 2025
+24.7%
Mar 2025
+28.3%
Dec 2024
+24.7%
Sep 2024
+25.3%
At each fiscal year end
Single quarter
Free cash flow, TTM
$105.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM UVSP
FY Dec 2025
$96.9M
FY Dec 2024
$72.0M
FY Dec 2023
$83.0M
FY Dec 2022
$104.2M
FY Dec 2021
$96.5M
Jun 2026
$22.9M
Mar 2026
$21.6M
Dec 2025
$30.0M
Sep 2025
$31.4M
Jun 2025
$21.9M
Mar 2025
$13.7M
Dec 2024
$27.4M
Sep 2024
$38.3M
At each fiscal year end
Single quarter
Debt to equity
0.24x
long-term 2020-03-31 (76 months older than the period end) plus current 2026-06-30; equity 2026-06-30
Debt to equity UVSP
FY Dec 2025
0.25x
FY Dec 2024
0.25x
FY Dec 2023
0.26x
FY Dec 2022
0.52x
FY Dec 2021
0.30x
Jun 2026
0.24x
Mar 2026
0.25x
Dec 2025
0.25x
Sep 2025
0.24x
Jun 2025
0.24x
Mar 2025
0.24x
Dec 2024
0.25x
Sep 2024
0.25x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.48x
TTM operating cash flow over long-term 2020-03-31 (76 months older than the period end) plus current 2026-06-30
Cash flow to debt UVSP
FY Dec 2025
0.43x
FY Dec 2024
0.34x
FY Dec 2023
0.41x
FY Dec 2022
0.27x
FY Dec 2021
0.44x
Jun 2026
0.48x
Mar 2026
0.46x
Dec 2025
0.43x
Sep 2025
0.45x
Jun 2025
0.49x
Mar 2025
0.37x
Dec 2024
0.34x
Sep 2024
0.34x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity UVSP
FY Dec 2025
+9.9%
FY Dec 2024
+8.8%
FY Dec 2023
+8.8%
FY Dec 2022
+10.1%
FY Dec 2021
+12.5%
Jun 2026
+10.5%
Mar 2026
+10.3%
Dec 2025
+9.9%
Sep 2025
+9.6%
Jun 2025
+9.0%
Mar 2025
+8.9%
Dec 2024
+8.8%
Sep 2024
+8.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets UVSP
FY Dec 2025
+1.1%
FY Dec 2024
+1.0%
FY Dec 2023
+0.9%
FY Dec 2022
+1.1%
FY Dec 2021
+1.4%
Jun 2026
+1.2%
Mar 2026
+1.2%
Dec 2025
+1.1%
Sep 2025
+1.0%
Jun 2025
+1.0%
Mar 2025
+1.0%
Dec 2024
+1.0%
Sep 2024
+0.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital UVSP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed UVSP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.21x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing UVSP
FY Dec 2025
10.43x
FY Dec 2024
11.44x
FY Dec 2023
9.14x
FY Dec 2022
9.90x
FY Dec 2021
9.59x
Jun 2026
12.64x
Mar 2026
10.29x
Dec 2025
10.43x
Sep 2025
10.04x
Jun 2025
11.00x
Mar 2025
10.66x
Dec 2024
11.44x
Sep 2024
11.30x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value UVSP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+9.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield UVSP
FY Dec 2025
+10.4%
FY Dec 2024
+8.4%
FY Dec 2023
+12.8%
FY Dec 2022
+13.6%
FY Dec 2021
+10.9%
Jun 2026
+8.7%
Mar 2026
+10.9%
Dec 2025
+10.4%
Sep 2025
+10.9%
Jun 2025
+11.7%
Mar 2025
+9.1%
Dec 2024
+8.4%
Sep 2024
+8.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.46x
P/E over trailing EPS growth of 27%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing UVSP
FY Dec 2025
0.48x
FY Dec 2024
1.62x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.10x
Jun 2026
0.47x
Mar 2026
0.41x
Dec 2025
0.48x
Sep 2025
0.50x
Jun 2025
0.93x
Mar 2025
0.94x
Dec 2024
1.62x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
UVSP ranks highest on growth (68th percentile) and institutional and government (61st), and lowest on insider conviction (10th), among Banks peers.
Profitability
57
Inputs
Return on equity+10.5% · 51 pct, sector of 327
Return on assets+1.2% · 63 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
52
Inputs
Debt to equity0.24x · 49 pct, sector of 229
Cash flow to debt0.48x · 56 pct, sector of 198
Growth
68
Inputs
Revenue growth, YoY+9.6% · 68 pct, sector of 151
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
10
Inputs
Net Form 4 buying (codes P and S), 180d-$1.6M · 21 pct, sector of 274
Insider buyers, 180d0 · 0 pct, sector of 274
Institutional and government
61
Inputs
Funds adding, latest quarter111 · 61 pct, sector of 257
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
40
Inputs
Short interest, % of float+3.7% · 44 pct, sector of 378
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+15.4% · 37 pct, sector of 127
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
UVSP filings, in plain words
Are Univest Financial insiders buying or selling UVSP?
In the 180 days to 2026-10-27, Univest Financial insiders were net sellers, a net $1.6M across purchases and sales reported on Form 4, by 6 sellers.
Have members of Congress traded UVSP?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by Jefferson Shreve dated 2025-05-12.
Are there planned insider sales of UVSP?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $340.0K of stock; the latest, by Michael Turner, was filed 2026-08-13.
Read the full summary
In the 180 days to 2026-10-27, Univest Financial insiders were net sellers of UVSP, a net $1.6M across purchases and sales reported on Form 4 by 6 sellers. None of the 6 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in UVSP, none in the last year; the latest on record is a sale by Jefferson Shreve dated 2025-05-12. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $340.0K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.